SILVERMAN LOU - Insider Non-Derivative Transactions at Oncocyte Corp (OCX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 23, 2023, SILVERMAN LOU's relationship to Oncocyte Corp (OCX) is Director, and currently has 31,270 shares of Common Stock, no par value.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OCX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

SILVERMAN LOU - Insider Non-Derivative Transactions of OCX Common Stock, no par value

SILVERMAN LOU - Insider Non-Derivative Transactions at OCX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 24, 2023	Acquisition -- (Common Stock, no par value)	25000	0	31270